menu
    • menu

    Find Azacitidine manufacturers, exporters & distributors on PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 5-azacytidine, 320-67-2, Azacytidine, Ladakamycin, Vidaza, Mylosar
    Molecular Formula
    C8H12N4O5
    Molecular Weight
    244.20  g/mol
    InChI Key
    NMUSYJAQQFHJEW-KVTDHHQDSA-N
    FDA UNII
    M801H13NRU
    Azacitidine
    A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
    Azacitidine is a Nucleoside Metabolic Inhibitor. The mechanism of action of azacitidine is as a Nucleic Acid Synthesis Inhibitor.
    1 2D Structure

    Azacitidine

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
    2.1.2 InChI
    InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
    2.1.3 InChI Key
    NMUSYJAQQFHJEW-KVTDHHQDSA-N
    2.1.4 Canonical SMILES
    C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N
    2.1.5 Isomeric SMILES
    C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
    2.2 Other Identifiers
    2.2.1 UNII
    M801H13NRU
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5 Azacytidine

    2. 5-azacytidine

    3. Azacytidine

    4. Nsc 102816

    5. Nsc-102816

    6. Nsc102816

    7. Vidaza

    2.3.2 Depositor-Supplied Synonyms

    1. 5-azacytidine

    2. 320-67-2

    3. Azacytidine

    4. Ladakamycin

    5. Vidaza

    6. Mylosar

    7. 5-azacitidine

    8. Azacitidinum

    9. Azacitidina

    10. Azacitidinum [inn-latin]

    11. 5-azac

    12. Azacitidina [inn-spanish]

    13. Nsc-102816

    14. U-18496

    15. Onureg

    16. Nsc 102816

    17. 4-amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1h)-one

    18. 4-amino-1-beta-d-ribofuranosyl-s-triazin-2(1h)-one

    19. Nsc102816

    20. 5azac

    21. Antibiotic U 18496

    22. 4-amino-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1h)-one

    23. Chebi:2038

    24. M801h13nru

    25. 4-amino-1-(beta-d-ribofuranosyl)-1,3,5-triazin-2(1h)-one

    26. U-18,496

    27. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one

    28. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one

    29. Wr-183027

    30. Ncgc00090851-04

    31. Dsstox_cid_116

    32. U 18496

    33. Dsstox_rid_75378

    34. Dsstox_gsid_20116

    35. C8h12n4o5

    36. 1,3,5-triazin-2(1h)-one, 4-amino-1-.beta.-d-ribofuranosyl-

    37. Mfcd00006539

    38. Ccris 60

    39. Smr000857239

    40. Vidaza (tn)

    41. Hsdb 6879

    42. 5-aza-cr

    43. Sr-01000075662

    44. Einecs 206-280-2

    45. Brn 0620461

    46. Unii-m801h13nru

    47. Azacitidine (jan/usan/inn)

    48. Azacitidine [usan:inn:ban]

    49. 4-amino-1-beta-d-ribofuranosyl-1,3,5-traizin-2(1h)-one

    50. Ns-17

    51. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one

    52. Cas-320-67-2

    53. Azacitidine (vidaza)

    54. 2-(beta-d-ribofuranosyl)-4-amino-1,3,5-triazin-2-one

    55. Antibiotic U18496

    56. U18496

    57. Spectrum_001262

    58. 4-amino-1-beta-d-ribofuranosyl-1,3,5-triazine-2(1h)-one

    59. Azacitidine [mi]

    60. Spectrum2_000786

    61. Spectrum3_001509

    62. Spectrum4_000922

    63. Spectrum5_001166

    64. Azacitidine [inn]

    65. Azacitidine [jan]

    66. Azacitidine [hsdb]

    67. Azacitidine [iarc]

    68. Azacitidine [usan]

    69. Molmap_000062

    70. 4-amino-1-.beta.-d-ribofuranosyl-s-triazin-2(1h)-one

    71. A 2385

    72. Azacitidine [vandf]

    73. Schembl3741

    74. Azacitidine [mart.]

    75. Chembl1489

    76. Azacitidine (5-azacytidine)

    77. Lopac0_000035

    78. Azacitidine [usp-rs]

    79. Azacitidine [who-dd]

    80. Bspbio_003157

    81. Kbiogr_001444

    82. Kbiogr_002556

    83. Kbioss_001742

    84. Kbioss_002565

    85. Mls001333121

    86. Mls001333122

    87. Mls002153249

    88. Mls002548894

    89. Divk1c_000125

    90. Spectrum1502111

    91. Spbio_000892

    92. Azacitidine [ema Epar]

    93. Gtpl6796

    94. Dtxsid9020116

    95. S-triazin-2(1h)-one, 4-amino-1-beta-d-ribofuranosyl-

    96. Bcbcmap01_000083

    97. Hms500g07

    98. Kbio1_000125

    99. Kbio2_001742

    100. Kbio2_002556

    101. Kbio2_004310

    102. Kbio2_005124

    103. Kbio2_006878

    104. Kbio2_007692

    105. Kbio3_002657

    106. Kbio3_003034

    107. Nmusyjaqqfhjew-kvtdhhqdsa-

    108. Azacitidine [orange Book]

    109. Pyrimidine Antimetabolite: Inhibits Nucleic Acid Replication

    110. Cmap_000082

    111. Ninds_000125

    112. Hms1921j22

    113. Hms2092d08

    114. Hms2231f15

    115. Hms3259d19

    116. Hms3260g11

    117. Pharmakon1600-01502111

    118. Zinc3861768

    119. 5-azacytidine, >=98% (hplc)

    120. Tox21_111032

    121. Tox21_302985

    122. Tox21_500035

    123. Bdbm50424715

    124. Ccg-39046

    125. Nsc758186

    126. S1782

    127. Onureg (cc-486; Oral Azacitidine)

    128. Akos015896938

    129. Tox21_111032_1

    130. Am83944

    131. Cs-1287

    132. Db00928

    133. Lp00035

    134. Nc00672

    135. Nsc-758186

    136. Nsc103-627

    137. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz

    138. Idi1_000125

    139. Ncgc00090851-01

    140. Ncgc00090851-02

    141. Ncgc00090851-03

    142. Ncgc00090851-05

    143. Ncgc00090851-06

    144. Ncgc00090851-07

    145. Ncgc00090851-08

    146. Ncgc00090851-10

    147. Ncgc00090851-14

    148. Ncgc00090851-22

    149. Ncgc00178234-01

    150. Ncgc00256541-01

    151. Ncgc00260720-01

    152. As-13697

    153. Hy-10586

    154. Sri-10756_10

    155. Sri-10756_12

    156. Wr183027

    157. Db-006955

    158. Sl-000003

    159. Eu-0100035

    160. D03021

    161. F10504

    162. 320a672

    163. A821115

    164. Q416451

    165. J-700085

    166. Sr-01000075662-1

    167. Sr-01000075662-3

    168. Sr-01000075662-7

    169. Brd-k03406345-001-02-1

    170. Brd-k03406345-001-27-8

    171. 4-amino-1-?-d-ribofuranosyl-1,3,5-triazin-2(1h)-one

    172. Z1522566611

    173. 4-amino-1-(bet.-d-ribofuranosyl)-1,3,5-triazin-2(1h)-one

    174. 4-amino-1-beta-d-ribofuranosyl-1,3,5-tr Iazin-2(1h)-one

    175. Azacitidine, United States Pharmacopeia (usp) Reference Standard

    176. 4-amino-1-(beta-d-ribofuranosyl)-1,3,5-triazin-2(1h)-one; Ladakamycin

    177. Azacitidine, Pharmaceutical Secondary Standard; Certified Reference Material

    178. 1401238-97-8

    179. 5-azacytidine, Hybri-max(tm), Gamma-irradiated, Lyophilized Powder, Bioxtra, Suitable For Hybridoma

    180. 5ae

    181. 6-amino-3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-1,3,5-triazin-3-ium-2-one

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 244.20 g/mol
    Molecular Formula C8H12N4O5
    XLogP3-2.2
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count2
    Exact Mass244.08076950 g/mol
    Monoisotopic Mass244.08076950 g/mol
    Topological Polar Surface Area141 Ų
    Heavy Atom Count17
    Formal Charge0
    Complexity384
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameAzacitidine
    PubMed HealthAzacitidine (Injection)
    Drug ClassesAntineoplastic Agent
    Drug LabelVidaza (azacitidine for injectable suspension) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine. Azacitidine is 4-amino-1--D-ribofuranosyl-s-triazin-2(1H)-one. The structural formula is as follows:The empirical formula i...
    Active IngredientAzacitidine
    Dosage FormInjectable
    RouteIntravenous, subcutaneous
    Strength100mg/vial
    Market StatusPrescription
    CompanyDr Reddys Labs

    2 of 4  
    Drug NameVidaza
    PubMed HealthAzacitidine (Injection)
    Drug ClassesAntineoplastic Agent
    Drug LabelVidaza (azacitidine for injectable suspension) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine. Azacitidine is 4-amino-1--D-ribofuranosyl-s-triazin-2(1H)-one. The structural formula is as follows:The empirical formula i...
    Active IngredientAzacitidine
    Dosage FormInjectable
    RouteIntravenous, subcutaneous
    Strength100mg/vial
    Market StatusPrescription
    CompanyCelgene

    3 of 4  
    Drug NameAzacitidine
    PubMed HealthAzacitidine (Injection)
    Drug ClassesAntineoplastic Agent
    Drug LabelVidaza (azacitidine for injectable suspension) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine. Azacitidine is 4-amino-1--D-ribofuranosyl-s-triazin-2(1H)-one. The structural formula is as follows:The empirical formula i...
    Active IngredientAzacitidine
    Dosage FormInjectable
    RouteIntravenous, subcutaneous
    Strength100mg/vial
    Market StatusPrescription
    CompanyDr Reddys Labs

    4 of 4  
    Drug NameVidaza
    PubMed HealthAzacitidine (Injection)
    Drug ClassesAntineoplastic Agent
    Drug LabelVidaza (azacitidine for injectable suspension) contains azacitidine, which is a pyrimidine nucleoside analog of cytidine. Azacitidine is 4-amino-1--D-ribofuranosyl-s-triazin-2(1H)-one. The structural formula is as follows:The empirical formula i...
    Active IngredientAzacitidine
    Dosage FormInjectable
    RouteIntravenous, subcutaneous
    Strength100mg/vial
    Market StatusPrescription
    CompanyCelgene

    4.2 Therapeutic Uses

    Anticancer agent used to treat acute myclogenous leukemia

    Kirk-Othmer Encyclopedia of Chemical Technology. 4th ed. Volumes 1: New York, NY. John Wiley and Sons, 1991-Present., p. V5 (1993) 872

    Expl Ther: The ability of phenylacetate to prevent carcinogenesis by the chemotherapeutic hypomethylating drug 5-aza-2'-deoxycytidine (5AzadC) was tested in vitro and in mice. Transient exposure of immortalized, but poorly tumorigenic ras-transformed 4C8 fibroblasts to 5AzadC resulted in neoplastic transformation manifested by loss of contact inhibition of growth, acquired invasiveness, and increased tumorigenicity in athymic mice.

    Prasanna P et al; Clin Cancer Res 1 (8): 865-71

    5-Azacytidine, an inhibitor of DNA methylation as well as a cytidine antimetabolite, becomes incorporated predominantly into RNA and has antileukemic and differentiating action. A newer analog, 2',2'-difluorodeoxycytidine (gemcitabine), becomes incorporated into DNA and inhibits the elongation of nascent DNA strands. It has promising activity in various human solid tumors, including lung cancer and ovarian cancer ... .

    Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 1249

    4.3 Drug Indication

    For treatment of patients with the following French-American-British myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (now classified as acute myelogenous leukemia with multilineage dysplasia), and chronic myelomonocytic leukemia.

    FDA Label

    Azacitidine Mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    - intermediate 2 and high risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),

    - chronic myelomonocytic leukaemia (CMML) with 10 29% marrow blasts without myeloproliferative disorder,

    - acute myeloid leukaemia (AML) with 20 30% blasts and multi lineage dysplasia, according to World Health Organisation (WHO) classification,

    - AML with > 30% marrow blasts according to the WHO classification.

    Azacitidine betapharm is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    - intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),

    - chronic myelomonocytic leukaemia (CMML) with 10 % to 29 % marrow blasts without myeloproliferative disorder,

    - acute myeloid leukaemia (AML) with 20 % to 30 % blasts and multi-lineage dysplasia, according to World Health Organization (WHO) classification,

    - AML with > 30 % marrow blasts according to the WHO classification.

    Azacitidine Accord is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    - intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),

    - chronic myelomonocytic leukaemia (CMML) with 10-29 % marrow blasts without myeloproliferative disorder,

    - acute myeloid leukaemia (AML) with 20-30 % blasts and multi-lineage dysplasia, according to World Health Organisation (WHO) classification,

    - AML with > 30% marrow blasts according to the WHO classification.

    Azacitidine Celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    - intermediate 2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),

    - chronic myelomonocytic leukaemia (CMML) with 10 29 % marrow blasts without myeloproliferative disorder,

    - acute myeloid leukaemia (AML) with 20 30 % blasts and multi-lineage dysplasia, according to World Health Organisation (WHO) classification,

    - AML with > 30% marrow blasts according to the WHO classification.

    Vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    - intermediate 2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),

    - chronic myelomonocytic leukaemia (CMML) with 10 29 % marrow blasts without myeloproliferative disorder,

    - acute myeloid leukaemia (AML) with 20 30 % blasts and multi-lineage dysplasia, according to World Health Organisation (WHO) classification.

    Vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for HSCT with AML with > 30% marrow blasts according to the WHO classification.

    Treatment of myelodysplastic syndrome (including juvenile myelomonocytic leukaemia), Treatment of acute myeloid leukaemia

    Onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (AML) who achieved complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (HSCT).

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Azacitidine is believed to exert its antineoplastic effects by causing hypomethylation of DNA and direct cytotoxicity on abnormal hematopoietic cells in the bone marrow. The concentration of azacitidine required for maximum inhibition of DNA methylation in vitro does not cause major suppression of DNA synthesis. Hypomethylation may restore normal function to genes that are critical for differentiation and proliferation. The cytotoxic effects of azacitidine cause the death of rapidly dividing cells, including cancer cells that are no longer responsive to normal growth control mechanisms. Non-proliferating cells are relatively insensitive to azacitidine. Upon uptake into cells, azacitidine is phosphorylated to 5-azacytidine monophosphate by uridine-cytidine kinase, then to diphosphate by pyrimidine monophosphate kinases and triphosphate by diphosphate kinases. 5-Azacitidine triphosphate is incorporated into RNA, leading to the disruption of nuclear and cytoplasmic RNA metabolism and inhibition of protein synthesis. 5-Azacytidine diphosphate is reduced to 5-aza-deoxycytidine diphosphate by ribonucleotide reductase. The resultant metabolite is phosphorylated to 5-azadeoxycitidine triphosphate by nucleoside diphosphate kinases. 5-azadeoxycitidine triphosphate is then incoporated into DNA, leading to inhibition of DNA synthesis. Azacitidine is most toxic during the S-phase of the cell cycle.

    5.2 MeSH Pharmacological Classification

    Antimetabolites, Antineoplastic

    Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    AZACITIDINE
    5.3.2 FDA UNII
    M801H13NRU
    5.3.3 Pharmacological Classes
    Nucleoside Metabolic Inhibitor [EPC]; Nucleic Acid Synthesis Inhibitors [MoA]
    5.4 ATC Code

    L01BC07

    L01BC07

    L01BC07

    L01BC07

    L01BC07

    L01BC07

    L01BC07

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

    L - Antineoplastic and immunomodulating agents

    L01 - Antineoplastic agents

    L01B - Antimetabolites

    L01BC - Pyrimidine analogues

    L01BC07 - Azacitidine

    5.5 Absorption, Distribution and Excretion

    Absorption

    Azacitidine is rapidly absorbed after subcutaneous administration. The bioavailability of subcutaneous azacitidine relative to IV azacitidine is approximately 89%, based on area under the curve.

    Route of Elimination

    Following IV administration of radioactive azacitidine to 5 cancer patients, the cumulative urinary excretion was 85% of the radioactive dose. Fecal excretion accounted for <1% of administered radioactivity over three days. Mean excretion of radioactivity in urine following SC administration of 14C-azacitidine was 50%.

    Volume of Distribution

    76 26 L

    Clearance

    167 +/- 49 L/h

    5.6 Metabolism/Metabolites

    An in vitro study of azacitidine incubation in human liver fractions indicated that azacitidine may be metabolized by the liver. The potential of azacitidine to inhibit cytochrome P450 (CYP) enzymes is not known.

    5.7 Biological Half-Life

    Mean elimination half-life is approximately 4 hours.

    5.8 Mechanism of Action

    Azacitidine (5-azacytidine) is a chemical analogue of the cytosine nucleoside used in DNA and RNA. Azacitidine may induce antineoplastic activity by inhibition of DNA methyltransferase at low doses and cytotoxicity through incorporation into RNA and DNA at high doses. Covalent binding to DNA methyltransferase results in hypomethylation of DNA and prevents DNA synthesis. As azacitidine is a ribonucleoside, it incoporates into RNA to a larger extent than into DNA. The incorporation into RNA leads to the dissembly of polyribosomes, defective methylation and acceptor function of transfer RNA, and inhibition of the production of protein, resulting in cell death.

    Telomerase activation is thought to be a critical step in cellular immortality and oncogenesis. Several reagents including differentiation-inducing and antineoplastic agents are known to inhibit telomerase activity, although the molecular mechanisms through which they inhibit telomerase activity remain unclear. Demethylating reagents have recently been used as potential antineoplastic drugs for some types of cancers including those of the prostate. In the present study, we examined the effect of the demethylating reagent 5-azacytidine (5-aza-CR) on telomerase activity using cells of two prostate cancer cell lines, DU-145 and TSU-PR1. 5-aza-CR treatment significantly reduced telomerase activity in TSU-PR1 cells, but not in DU-145 cells, although growth inhibition was observed to a similar extent in both cell lines. Reverse transcription-PCR analyses revealed that inhibition of telomerase activity was accompanied by down-regulation of telomerase catalytic subunit (hTERT) mRNA expression. Transient expression assays showed that 5-aza-CR repressed the transcriptional activity of the hTERT promoter and that the E-box within the core promoter was responsible for this down-regulation. Western blot analyses revealed that 5-aza-CR reactivated p16 expression and repressed c-Myc expression in TSU-PR1 cells but not in DU-145 cells. Overexpression of p16 in TSU-PR1 cells led to significant repression of c-Myc transcription. These findings suggest that 5-aza-CR inhibits telomerase activity via transcriptional repression of hTERT, in which p16 and c-Myc may play a key role.

    PMID:10914736 Kitagawa Y et al; Clin cancer Res 6 (7): 2868-75 (2000)

    Cellular differentiation is controlled by a variety of factors including gene methylation, which represses particular genes as cell fate is determined. The incorporation of 5-azacytidine (5azaC) into DNA in vitro prevents methylation and thus can alter cellular differentiation pathways. Human bone marrow fibroblasts and MG63 cells treated with 5azaC were used as models of osteogenic progenitors and of a more mature osteoblast phenotype, respectively. The capacity for differentiation of these cells following treatment with glucocorticoids was investigated. 5azaC treatment led to significant expression of the osteoblastic marker alkaline phosphatase in MG63 osteosarcoma cells, which was further augmented by glucocorticoids; however, in human marrow fibroblasts alkaline phosphatase activity was only observed in glucocorticoid-treated cultures. MG63 cells represent a phenotype late in the osteogenic lineage in which demethylation is sufficient to induce alkaline phosphatase activity. Marrow fibroblasts are at an earlier stage of differentiation and require stimulation with glucocorticoids. In contrast, the expression of osteocalcin, an osteoblastic marker, was unaffected by 5azaC treatment, suggesting that regulation of expression of the osteocalcin gene does not involve methylation. These models provide novel approaches to the study of the control of differentiation in the marrow fibroblastic system.

    Locklin RM et al; Cell Biol Int 22 (3): 207-15

    API SUPPLIERS

    read-more
    read-more

    01

    ChemWerth Inc

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-01-26

    Pay. Date : 2022-12-16

    DMF Number : 23416

    Submission : 2009-12-22

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Chemwerth Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioFlorida Conference
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    DKSH

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Fi Europe 2024
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    DKSH Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2020-11-20

    Pay. Date : 2020-11-17

    DMF Number : 23564

    Submission : 2010-02-23

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 302MF10075

    Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA

    Initial Date of Registration : 2020-07-01

    Latest Date of Registration : --

     EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-06

    Valid Till : 2025-07-07

    Written Confirmation Number : WC-0039

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Boryeong Co., Ltd.

    Registration Date : 2017-09-29

    Registration Number : Su249-4-ND

    Manufacturer Name : Dr. Reddy's Laboratories Limited

    Manufacturer Address : Chemical Technical Operations-Unit I, Plot Nos. 137, 138, 145 & 146 Sri Venkateswara Co-operative industrial Estate, Bollaram Village, Jinnaram Mandal Sangareddy District, Telangana, India. Pin Code – 502 325

     VMF Others AUDIT
    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Chongqing Sintaho Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChongqing Sintaho Pharma: A trusted partner globally for chemosynthetic APIs.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 84172-112

    Start Marketing Date : 2024-07-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chongqing Sintaho Pharmaceutical

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    HRV Global Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #2.D38
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, ASMF arrow-down
    ✖
    Available Reg Filing : AU, ASMF
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Qilu Antibiotics Pharmaceutical Co...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Qilu Antibiotics Pharmaceutical Co...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-12-18

    Pay. Date : 2015-09-24

    DMF Number : 29771

    Submission : 2015-09-25

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sun Pharmaceutical Industries Limi...

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limi...

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-02-15

    Pay. Date : 2015-10-07

    DMF Number : 29864

    Submission : 2016-09-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Shilpa Medicare

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Shilpa Medicare

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-03-15

    Pay. Date : 2013-09-23

    DMF Number : 27487

    Submission : 2013-09-23

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 303MF10033

    Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584135, Karnataka, India

    Initial Date of Registration : 2021-02-16

    Latest Date of Registration : --

     EU-WCInactive-api
    ✖

    Date of Issue : 2019-07-05

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-0147

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 82920-015

    Start Marketing Date : 2022-08-11

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Samyang Holdings Co., Ltd.

    Registration Date : 2018-06-25

    Registration Number : No. 163-15-ND(1)

    Manufacturer Name : Shilpa Medicare Limited

    Manufacturer Address : Plot No.33, 33A, 40 to 47, Block C,D,E,H,I & AM, Raichur Industrial Growth Centre, Chicksugur - 584 134 Dist: Raichur, Karnataka India

     VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Ash Stevens, Inc.

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Ash Stevens, Inc.

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3562

    Submission : 1979-07-09

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Korea BMS Pharmaceutical Co., Ltd.

    Registration Date : 2010-07-30

    Registration Number : No. 5284-1-ND

    Manufacturer Name : Ash Stevens LLC.

    Manufacturer Address : 18655 Krause St., Riverview, MI 48193

     VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1610476200,"product":"AZACITIDINE(QTY:315 GMS)","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG BIOPHARMACEUTICALS","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.32","actualQuantity":"315","unit":"GMS","unitRateFc":"34.5","totalValueFC":"11002.4","currency":"USD","unitRateINR":2554.5449206349208,"date":"13-Jan-2021","totalValueINR":"804681.65","totalValueInUsd":"11002.4","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"7878800","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1611253800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES BA","customer":"LABORATORIO LKM SA","customerCountry":"ARGENTINA","quantity":"2.50","actualQuantity":"2.5","unit":"KGS","unitRateFc":"38205.5","totalValueFC":"96706.3","currency":"USD","unitRateINR":2829117.1920000003,"date":"22-Jan-2021","totalValueINR":"7072792.98","totalValueInUsd":"96706.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8088953","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1611945000,"product":"AZACITIDINE","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"CHICAGO, IL","customer":"SINGOTA SOLUTIONS","customerCountry":"UNITED STATES","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"135000","totalValueFC":"399265.3","currency":"USD","unitRateINR":9733666.666666666,"date":"30-Jan-2021","totalValueINR":"29201000","totalValueInUsd":"399265.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8286877","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1614709800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"NANG KUANG PHARMACEUTICAL CO. LTD.","customerCountry":"TAIWAN","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"47880.1","totalValueFC":"71078.8","currency":"USD","unitRateINR":3449759.52,"date":"03-Mar-2021","totalValueINR":"5174639.28","totalValueInUsd":"71078.8","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9067808","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1614796200,"product":"AZACITIDINE IH","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA","customerCountry":"BRAZIL","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"24587.2","totalValueFC":"36500.1","currency":"USD","unitRateINR":1771506,"date":"04-Mar-2021","totalValueINR":"2657259","totalValueInUsd":"36500.1","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9114402","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1615487400,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES BA","customer":"LABORATORIO LKM SA","customerCountry":"ARGENTINA","quantity":"2.50","actualQuantity":"2500","unit":"GMS","unitRateFc":"39.6","totalValueFC":"98061.5","currency":"USD","unitRateINR":2855.6055920000003,"date":"12-Mar-2021","totalValueINR":"7139013.98","totalValueInUsd":"98061.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9297696","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1616524200,"product":"AZACITIDINE","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"4.03","actualQuantity":"4.034","unit":"KGS","unitRateFc":"49654.8","totalValueFC":"198240","currency":"USD","unitRateINR":3577627.2954883492,"date":"24-Mar-2021","totalValueINR":"14432148.51","totalValueInUsd":"198240","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9599804","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q2","strtotime":1621017000,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"4.66","actualQuantity":"4.66","unit":"KGS","unitRateFc":"30205","totalValueFC":"138450.6","currency":"USD","unitRateINR":2176269.2317596562,"date":"15-May-2021","totalValueINR":"10141414.62","totalValueInUsd":"138450.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"1782799","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q2","strtotime":1621362600,"product":"AZACITIDINE IH","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA","customerCountry":"BRAZIL","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"24797.5","totalValueFC":"12195.7","currency":"USD","unitRateINR":1786660,"date":"19-May-2021","totalValueINR":"893330","totalValueInUsd":"12195.7","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"1861485","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624559400,"product":"AZACITIDINE","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES BA","customer":"IVAX ARGENTINA S.A.","customerCountry":"ARGENTINA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"110113.8","totalValueFC":"10787.5","currency":"USD","unitRateINR":7933700.0999999996,"date":"25-Jun-2021","totalValueINR":"793370.01","totalValueInUsd":"10787.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"2683393","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624645800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"HANNOVER","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"7.00","actualQuantity":"7000","unit":"GMS","unitRateFc":"37.4","totalValueFC":"256272.1","currency":"USD","unitRateINR":2692.5281942857141,"date":"26-Jun-2021","totalValueINR":"18847697.36","totalValueInUsd":"256272.1","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"2693549","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1624905000,"product":"AZACITIDINE","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"BIOPROFARMA BAGO S.A","customerCountry":"ARGENTINA","quantity":"0.17","actualQuantity":"0.17","unit":"KGS","unitRateFc":"45499.7","totalValueFC":"7577.6","currency":"USD","unitRateINR":3278249.9999999995,"date":"29-Jun-2021","totalValueINR":"557302.5","totalValueInUsd":"7577.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"2773788","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627410600,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"6.52","actualQuantity":"6.52","unit":"KGS","unitRateFc":"30537","totalValueFC":"192484.5","currency":"USD","unitRateINR":2200190.855828221,"date":"28-Jul-2021","totalValueINR":"14345244.38","totalValueInUsd":"192484.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"3446619","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627669800,"product":"AZACITIDINE","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"LOTUS PHARMACEUTICAL","customerCountry":"TAIWAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"15254.1","totalValueFC":"14747.2","currency":"USD","unitRateINR":1099060.8300000001,"date":"31-Jul-2021","totalValueINR":"1099060.83","totalValueInUsd":"14747.2","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"3522110","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1631125800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"LJUBLJANA - BRNIK","customer":"SANDOZ B2B","customerCountry":"SLOVENIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"18000","totalValueFC":"53047.7","currency":"USD","unitRateINR":1300666.6666666667,"date":"09-Sep-2021","totalValueINR":"3902000","totalValueInUsd":"53047.7","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"4468713","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVENIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632681000,"product":"AZACITIDINE","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"STOCKHOLM - ARLANDA","customer":"NANEXA AB","customerCountry":"SWEDEN","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"40000","totalValueFC":"3956.1","currency":"USD","unitRateINR":2910000,"date":"27-Sep-2021","totalValueINR":"291000","totalValueInUsd":"3956.1","indian_port":"HYDERABAD AIR","hs_no":"29329990","bill_no":"4889540","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632940200,"product":"AZACITIDINE","address":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,","city":"RAICHUR , KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"SINGOTA SOLUTIONS","customerCountry":"UNITED STATES","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"85000","totalValueFC":"672082.4","currency":"USD","unitRateINR":6179500,"date":"30-Sep-2021","totalValueINR":"49436000","totalValueInUsd":"672082.4","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"4978165","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO.10, SHOP NO.80,RAJENDRA GUNJ ,, RAICHUR , KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637173800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,","city":"HYDEABAD.AP","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"CRISTALIA PRODUTOS QUIMICOS FARMA. LTDA","customerCountry":"BRAZIL","quantity":"2.58","actualQuantity":"2580","unit":"GMS","unitRateFc":"50","totalValueFC":"127928.6","currency":"USD","unitRateINR":3692.6356589147285,"date":"18-Nov-2021","totalValueINR":"9527000","totalValueInUsd":"127928.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6085919","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,ROAD NO. 7, BANJARA HILLS,, HYDEABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640543400,"product":"PHARMACEUTICALAZACITIDINE","address":"5\/502, GARDEN ESTATE,,OFF POKHRAN ROAD NO.2, THANE WEST","city":"THANE,MAHARASHTRA","supplier":"AMTEC HEALTHCARE PVT LTD","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"MERCURY EXPRESS TRADING ","customerCountry":"UNITED ARAB EMIRATES","quantity":"1.33","actualQuantity":"1325","unit":"GMS","unitRateFc":"28.1","totalValueFC":"37268.2","currency":"USD","unitRateINR":2121.5094339622642,"date":"27-Dec-2021","totalValueINR":"2811000","totalValueInUsd":"37268.2","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"7054713","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"5\/502, GARDEN ESTATE,,OFF POKHRAN ROAD NO.2, THANE WEST, THANE,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645381800,"product":"AZACITIDINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"6.08","actualQuantity":"6.075","unit":"KGS","unitRateFc":"30000","totalValueFC":"180770.6","currency":"USD","unitRateINR":2230452.6748971194,"date":"21-Feb-2022","totalValueINR":"13550000","totalValueInUsd":"180770.6","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8376028","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646245800,"product":"AZACITIDINE IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA","customerCountry":"BRAZIL","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"25000","totalValueFC":"7229.1","currency":"USD","unitRateINR":1836666.6666666667,"date":"03-Mar-2022","totalValueINR":"551000","totalValueInUsd":"7229.1","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"8650956","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648146600,"product":"AZACITIDINE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"BIOPROFARMA BAGO S ","customerCountry":"ARGENTINA","quantity":"0.40","actualQuantity":"0.4","unit":"KGS","unitRateFc":"45000","totalValueFC":"17764.5","currency":"USD","unitRateINR":3385000,"date":"25-Mar-2022","totalValueINR":"1354000","totalValueInUsd":"17764.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9196302","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648492200,"product":"AZACITIDINE","address":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD","city":"RAICHUR,KARNATAKA","supplier":"SHILPA MEDICARE","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG HOLDINGS CORPORATION","customerCountry":"KOREA, REPUBLIC OF","quantity":"12.00","actualQuantity":"12","unit":"KGS","unitRateFc":"110000","totalValueFC":"1301740.2","currency":"USD","unitRateINR":8268166.666666667,"date":"29-Mar-2022","totalValueINR":"99218000","totalValueInUsd":"1301740.2","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"9312601","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"12 6 214 A1, YERMARUS CAMP CROSS,H YDERABAD ROAD, RAICHUR,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648578600,"product":"AZACITIDINE, B.NO. VLS-AZA22003, MFG.DT.","address":"UnitNOB4054thFloorSagarTechPlaza SakinakaJunctionAndheriEast Contact","city":"Mumbai","supplier":"BASIL DRUGS AND ","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO KEMEX SA.","customerCountry":"ARGENTINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"25000","totalValueFC":"7347.2","currency":"USD","unitRateINR":1866666.6666666667,"date":"30-Mar-2022","totalValueINR":"560000","totalValueInUsd":"7347.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9353448","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"UnitNOB4054thFloorSagarTechPlaza SakinakaJunctionAndheriEast Contact, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664303400,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG BIOPHARMACEUTICALS","customerCountry":"KOREA, REPUBLIC OF","quantity":"4.31","actualQuantity":"4310","unit":"GMS","unitRateFc":"85","totalValueFC":"359516.1","currency":"USD","unitRateINR":6684.9187935034806,"date":"28-Sep-2022","totalValueINR":"28812000","totalValueInUsd":"359516.1","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"4489801","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1667154600,"product":"AZACITIDINE IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"TO THE ORDER OF","customerCountry":"BRAZIL","quantity":"1.45","actualQuantity":"1.45","unit":"KGS","unitRateFc":"20000","totalValueFC":"28972.8","currency":"USD","unitRateINR":1644137.9310344828,"date":"31-Oct-2022","totalValueINR":"2384000","totalValueInUsd":"28972.8","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"5158850","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670524200,"product":"AZACITIDINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG HOLDINGS CORPORATION","customerCountry":"KOREA, REPUBLIC OF","quantity":"2.00","actualQuantity":"2000","unit":"GMS","unitRateFc":"36","totalValueFC":"69812.7","currency":"USD","unitRateINR":2876.5,"date":"09-Dec-2022","totalValueINR":"5753000","totalValueInUsd":"69812.7","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6039269","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670869800,"product":"AZACITIDINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"LJUBLJANA - BRNIK","customer":"SANDOZ B2B","customerCountry":"SLOVENIA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"12000","totalValueFC":"2245","currency":"USD","unitRateINR":925000,"date":"13-Dec-2022","totalValueINR":"185000","totalValueInUsd":"2245","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6115914","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVENIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672079400,"product":"AZACITIDINE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"ACTAVIS INC","customerCountry":"TAIWAN","quantity":"3.92","actualQuantity":"3.916","unit":"KGS","unitRateFc":"11750","totalValueFC":"45603.3","currency":"USD","unitRateINR":959652.70684371807,"date":"27-Dec-2022","totalValueINR":"3758000","totalValueInUsd":"45603.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6483926","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672338600,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"LOS ANGELES","customer":"ASTEX PHARMACETICALS INC.,","customerCountry":"UNITED STATES","quantity":"25.00","actualQuantity":"25000","unit":"GMS","unitRateFc":"85","totalValueFC":"2109366.4","currency":"USD","unitRateINR":6953,"date":"30-Dec-2022","totalValueINR":"173825000","totalValueInUsd":"2109366.4","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"6582625","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673289000,"product":"AZACITIDINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO LKM SA","customerCountry":"ARGENTINA","quantity":"1.36","actualQuantity":"1.36","unit":"KGS","unitRateFc":"30000","totalValueFC":"40496.8","currency":"USD","unitRateINR":2434558.8235294116,"date":"10-Jan-2023","totalValueINR":"3311000","totalValueInUsd":"40496.8","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6846136","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675103400,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LABORATORIO KEMEX SA","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12059.8","currency":"USD","unitRateINR":1972,"date":"31-Jan-2023","totalValueINR":"986000","totalValueInUsd":"12059.8","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"7405523","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675103400,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BLOOMINGTON, IN","customer":"SINGOTA SOLUTIONS","customerCountry":"UNITED STATES","quantity":"25.00","actualQuantity":"25000","unit":"GMS","unitRateFc":"85","totalValueFC":"2093568","currency":"USD","unitRateINR":6846.7600000000002,"date":"31-Jan-2023","totalValueINR":"171169000","totalValueInUsd":"2093568","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"7414071","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675362600,"product":"AZACITIDINE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"BIOPROFARMA BAGO S ","customerCountry":"ARGENTINA","quantity":"0.60","actualQuantity":"0.6","unit":"KGS","unitRateFc":"45000","totalValueFC":"26492.3","currency":"USD","unitRateINR":3646666.666666667,"date":"03-Feb-2023","totalValueINR":"2188000","totalValueInUsd":"26492.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"7500775","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676658600,"product":"AZACITIDINE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"ACTAVIS INC","customerCountry":"TAIWAN","quantity":"29.56","actualQuantity":"29.557","unit":"KGS","unitRateFc":"11750","totalValueFC":"344000.4","currency":"USD","unitRateINR":961227.45880840416,"date":"18-Feb-2023","totalValueINR":"28411000","totalValueInUsd":"344000.4","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"7887427","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO KEMEX S.A","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12192.8","currency":"USD","unitRateINR":2014,"date":"28-Feb-2023","totalValueINR":"1007000","totalValueInUsd":"12192.8","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"8143755","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679941800,"product":"PHARMA INGREDIENTS - AZACITIDINE","address":"30, AROHI VILLA, S.P. RING ROAD, BOPAL,","city":"AHMEDABAD","supplier":"GREENCROSS EXPORT PRIVATE ","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"TO THE ORDER -- +-","customerCountry":"RUSSIA","quantity":"0.38","actualQuantity":"0.375","unit":"KGS","unitRateFc":"70000","totalValueFC":"26018.1","currency":"USD","unitRateINR":5706666.666666667,"date":"28-Mar-2023","totalValueINR":"2140000","totalValueInUsd":"26018.1","indian_port":"AHMEDABAD AIR","hs_no":"29329990","bill_no":"8859418","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"30, AROHI VILLA, S.P. RING ROAD, BOPAL,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1682706600,"product":"BULK DRUG ( AZACITIDINE )","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO KEMEX S.A","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12214.2","currency":"USD","unitRateINR":2002,"date":"29-Apr-2023","totalValueINR":"1001000","totalValueInUsd":"12214.2","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"9658620","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687890600,"product":"AZACITIDINE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"3.82","actualQuantity":"3818","unit":"GMS","unitRateFc":"35","totalValueFC":"132122.8","currency":"USD","unitRateINR":2844.4211079099005,"date":"28-Jun-2023","totalValueINR":"10859999.79","totalValueInUsd":"132122.8","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689618600,"product":"AZACITIDINE","address":"","city":"","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12179.2","currency":"USD","unitRateINR":2001.999636,"date":"18-Jul-2023","totalValueINR":"1000999.818","totalValueInUsd":"12179.2","indian_port":"HYDERABAD AIR","hs_no":"29419019","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689791400,"product":"AZACITIDINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO LKM SA","customerCountry":"ARGENTINA","quantity":"1.55","actualQuantity":"1552","unit":"GMS","unitRateFc":"30","totalValueFC":"45918.3","currency":"USD","unitRateINR":2431.7012377577321,"date":"20-Jul-2023","totalValueINR":"3774000.321","totalValueInUsd":"45918.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691692200,"product":"AZACITIDINE","address":"#N\/A","city":"#N\/A","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"NA","customer":"TO THE ORDER OF","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"24.6","totalValueFC":"12156.5","currency":"USD","unitRateINR":2013.9999520000001,"date":"11-Aug-2023","totalValueINR":"1006999.976","totalValueInUsd":"12156.5","indian_port":"HYDERABAD ICD","hs_no":"29419019","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"#N\/A, #N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695839400,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"TO THE ORDER OF","customerCountry":"UNITED STATES","quantity":"6.00","actualQuantity":"6000","unit":"GMS","unitRateFc":"85","totalValueFC":"505648.7","currency":"USD","unitRateINR":6995.5,"date":"28-Sep-2023","totalValueINR":"41973000","totalValueInUsd":"505648.7","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"4245099","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697394600,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO LKM SA","customerCountry":"ARGENTINA","quantity":"1.55","actualQuantity":"1552","unit":"GMS","unitRateFc":"28","totalValueFC":"42617.2","currency":"USD","unitRateINR":2285.4381443298971,"date":"16-Oct-2023","totalValueINR":"3547000","totalValueInUsd":"42617.2","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"4661828","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697740200,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER OF","customerCountry":"GREECE","quantity":"0.11","actualQuantity":"114","unit":"GMS","unitRateFc":"70","totalValueFC":"7773.7","currency":"USD","unitRateINR":5675.4385964912281,"date":"20-Oct-2023","totalValueINR":"647000","totalValueInUsd":"7773.7","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"4781831","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702492200,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"11.53","actualQuantity":"11.534","unit":"KGS","unitRateFc":"35000","totalValueFC":"400068.9","currency":"USD","unitRateINR":2887376.4522281946,"date":"14-Dec-2023","totalValueINR":"33303000","totalValueInUsd":"400068.9","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6036486","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702578600,"product":"AZACITIDINE IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"MICROSULES ARGENTINA S.A.","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"30000","totalValueFC":"14619.8","currency":"USD","unitRateINR":2434000,"date":"15-Dec-2023","totalValueINR":"1217000","totalValueInUsd":"14619.8","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"6065839","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703269800,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"15.04","actualQuantity":"15.04","unit":"KGS","unitRateFc":"35000","totalValueFC":"522565.5","currency":"USD","unitRateINR":2892287.2340425532,"date":"23-Dec-2023","totalValueINR":"43500000","totalValueInUsd":"522565.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6262738","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703529000,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"HANNOVER","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"2.00","actualQuantity":"2000","unit":"GMS","unitRateFc":"24","totalValueFC":"47571.5","currency":"USD","unitRateINR":1980,"date":"26-Dec-2023","totalValueINR":"3960000","totalValueInUsd":"47571.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6304010","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703701800,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"ATLANTA, HARTSFIELD","customer":"SOCIETAL CDMO","customerCountry":"UNITED STATES","quantity":"6.02","actualQuantity":"6020","unit":"GMS","unitRateFc":"85","totalValueFC":"508366.1","currency":"USD","unitRateINR":7029.568106312292,"date":"28-Dec-2023","totalValueINR":"42318000","totalValueInUsd":"508366.1","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"6371791","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703701800,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"ATLANTA, HARTSFIELD","customer":"SOCIETAL CDMO","customerCountry":"UNITED STATES","quantity":"6.02","actualQuantity":"6020","unit":"GMS","unitRateFc":"85","totalValueFC":"508366.1","currency":"USD","unitRateINR":7029.568106312292,"date":"28-Dec-2023","totalValueINR":"42318000","totalValueInUsd":"508366.1","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"6371794","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706812200,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"HANNOVER","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"10.00","actualQuantity":"10000","unit":"GMS","unitRateFc":"24","totalValueFC":"237624.9","currency":"USD","unitRateINR":1971.6636670000003,"date":"02-Feb-2024","totalValueINR":"19716636.67","totalValueInUsd":"237624.9","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"7213226","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708021800,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"HANNOVER","customer":"HIKMA PHARMACEUTICALS","customerCountry":"GERMANY","quantity":"6.00","actualQuantity":"6000","unit":"GMS","unitRateFc":"24","totalValueFC":"142509.2","currency":"USD","unitRateINR":1970.7543166666667,"date":"16-Feb-2024","totalValueINR":"11824525.9","totalValueInUsd":"142509.2","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"7571094","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708540200,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"BIOPROFARMA BAGO S ","customerCountry":"ARGENTINA","quantity":"0.60","actualQuantity":"600","unit":"GMS","unitRateFc":"45","totalValueFC":"26748.2","currency":"USD","unitRateINR":3699,"date":"22-Feb-2024","totalValueINR":"2219400","totalValueInUsd":"26748.2","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"7733463","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708626600,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"ATLANTA, HARTSFIELD","customer":"SOCIETAL CDMO","customerCountry":"UNITED STATES","quantity":"6.02","actualQuantity":"6020","unit":"GMS","unitRateFc":"85","totalValueFC":"506928.1","currency":"USD","unitRateINR":6987,"date":"23-Feb-2024","totalValueINR":"42061740","totalValueInUsd":"506928.1","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"7775531","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710700200,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"IVAX ARGENTINA S.A.","customerCountry":"ARGENTINA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"110000","totalValueFC":"10713.1","currency":"USD","unitRateINR":8895729,"date":"18-Mar-2024","totalValueINR":"889572.9","totalValueInUsd":"10713.1","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8413779","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718217000,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"DEVA HOLDING A.S. - CERKEZKOY 2","customerCountry":"TURKEY","quantity":"2.00","actualQuantity":"2000","unit":"GMS","unitRateFc":"30","totalValueFC":"59267.5","currency":"USD","unitRateINR":2473.8084650000001,"date":"13-Jun-2024","totalValueINR":"4947616.93","totalValueInUsd":"59267.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"1631286","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719340200,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"7.70","actualQuantity":"7.698","unit":"KGS","unitRateFc":"35000","totalValueFC":"266190.3","currency":"USD","unitRateINR":2886647.1369186803,"date":"26-Jun-2024","totalValueINR":"22221409.66","totalValueInUsd":"266190.3","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"1960059","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721413800,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"3.67","actualQuantity":"3.67","unit":"KGS","unitRateFc":"35000","totalValueFC":"126871.8","currency":"USD","unitRateINR":2889740.3051771116,"date":"20-Jul-2024","totalValueINR":"10605346.92","totalValueInUsd":"126871.8","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"2566197","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721845800,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO KEMEX SA","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12132.6","currency":"USD","unitRateINR":2028.3499999999999,"date":"25-Jul-2024","totalValueINR":"1014175","totalValueInUsd":"12132.6","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"2683757","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724783400,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG HOLDING CORPORATION","customerCountry":"REPUBLIC OF KOREA","quantity":"14.00","actualQuantity":"14","unit":"KGS","unitRateFc":"32000","totalValueFC":"443155.5","currency":"USD","unitRateINR":2655088.5085714282,"date":"28-Aug-2024","totalValueINR":"37171239.12","totalValueInUsd":"443155.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3538706","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725301800,"product":"AZACITIDINE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CHENGDU","customer":"KINDOS PHARMACEUTICALS CO ","customerCountry":"CHINA","quantity":"3.89","actualQuantity":"3.886","unit":"KGS","unitRateFc":"35000","totalValueFC":"134508","currency":"USD","unitRateINR":2900652.1178589812,"date":"03-Sep-2024","totalValueINR":"11271934.13","totalValueInUsd":"134508","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3718132","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726684200,"product":"AZACITIDINE","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"HIKMA PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"1.00","actualQuantity":"1000","unit":"GMS","unitRateFc":"23.1","totalValueFC":"22726.3","currency":"USD","unitRateINR":1904.4942100000001,"date":"19-Sep-2024","totalValueINR":"1904494.21","totalValueInUsd":"22726.3","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"4154593","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727461800,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SAMYANG HOLDING CORP","customerCountry":"REPUBLIC OF KOREA","quantity":"2.00","actualQuantity":"2000","unit":"GMS","unitRateFc":"75","totalValueFC":"148386.9","currency":"USD","unitRateINR":6217.5,"date":"28-Sep-2024","totalValueINR":"12435000","totalValueInUsd":"148386.9","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"4427916","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729189800,"product":"AZACITIDINE","address":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD","city":"RAICHUR","supplier":"SHILPA PHARMA LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIO KEMEX SA","customerCountry":"ARGENTINA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"25","totalValueFC":"12067.5","currency":"USD","unitRateINR":2027.98,"date":"18-Oct-2024","totalValueINR":"1013990","totalValueInUsd":"12067.5","indian_port":"Hyderabad Air","hs_no":"29419019","bill_no":"4916252","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"12 6 214 A1 SHILPA HOUSE HYDERABAD ROAD, RAICHUR","customerAddress":""},{"dataSource":"API Import","activeIngredients":"AZACITIDINE","year":"2021","qtr":"Q1","strtotime":1611858600,"product":"AZACITIDINE (BATCH NO. 71384AA0015)","address":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,","city":"MUMBAI, MAHARASHTRA.","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"TAIPEI","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.07","actualQuantity":"0.065","unit":"KGS","unitRateFc":"45000","totalValueFC":"2953.5","currency":"USD","unitRateINR":"3323250","date":"29-Jan-2021","totalValueINR":"216011.25","totalValueInUsd":"2953.5","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2555718","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIPEI","supplierAddress":"","customerAddress":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636655400,"product":"AZACITIDINE (AS PER TEST LIC.TL\/BDZ\/21\/000220 DT:20\/09\/2021)","address":"S.C.O.857, CABIN NO. 10, 2ND FLOOR ,,NAC, MANIMAJRA,","city":"CHANDIGARH,CHANDIGARH","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"NA","customer":"VENUS REMEDIES","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"47000","totalValueFC":"4768.1","currency":"USD","unitRateINR":"3550850","date":"12-Nov-2021","totalValueINR":"355085","totalValueInUsd":"4768.1","indian_port":"DELHI AIR","hs_no":"29419090","bill_no":"6226465","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"S.C.O.857, CABIN NO. 10, 2ND FLOOR ,,NAC, MANIMAJRA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1650825000,"product":"AZACITIDINE (QTY:1X150 MG,PRICE: USD 257)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00015","unit":"KGS","unitRateFc":"1713333.3","totalValueFC":"318.3","currency":"USD","unitRateINR":"160107466.7","date":"25-Apr-2022","totalValueINR":"24016.12","totalValueInUsd":"318.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"8412157","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676399400,"product":"AZACITIDINE (BATCH NO:71670RA004)","address":"6-3-348 MID TOWN,6TH FLOOR,","city":"HYDERABAD.AP","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"TAIPEI","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"35100","totalValueFC":"70336","currency":"USD","unitRateINR":"2904525","date":"15-Feb-2023","totalValueINR":"5809050","totalValueInUsd":"70336","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29339990","bill_no":"1000319","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIPEI","supplierAddress":"NO.1 NAN-KE 8TH ROAD SOUTHERN TAIWA N SCIENCE PARK SHAN-HUA TAINAN 7414","customerAddress":"6-3-348 MID TOWN,6TH FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689100200,"product":"AZACITIDINE","address":"ALEMBIC ROAD VADODARA Contact No: 919727727339","city":"GUJARAT","supplier":"SCINOPHARM TAIWAN, LTD","supplierCountry":"TAIWAN","foreign_port":"NA","customer":"ALEMBIC PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"0.248","unit":"KGS","unitRateFc":"40000","totalValueFC":"15370.1","currency":"USD","unitRateINR":"5093802.5","date":"12-Jul-2023","totalValueINR":"1263262.826","totalValueInUsd":"15370.1","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ALEMBIC ROAD VADODARA Contact No: 919727727339"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726770600,"product":"AZACITIDINE IMPURITIE - N","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"VISAKHAPATNAM SEZ","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.15","unit":"GMS","unitRateFc":"5889.3","totalValueFC":"895","currency":"USD","unitRateINR":"500000","date":"20-Sep-2024","totalValueINR":"75000","totalValueInUsd":"895","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29339990","bill_no":"5705659","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"VISAKHAPATNAM SEZ","supplierAddress":"FTO-7, PLOT NO.P1 TO P9, VSEZ, DUVV V.S.E.Z., DUVVADA, VISAKHAPATNAM SDNF India","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"}]
    13-Jan-2021
    18-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    AbbVie to Showcase Oncology Portfolio and Pipeline During the 2022 ASCO and EHA Annual Congresses

    Details:

    VENCLEXTA®/VENCLYXTO® (venetoclax) is a first-in-class medicine that selectively binds and inhibits B-cell lymphoma-2 (BCL-2) protein. In some blood cancers, BCL-2 prevents cancer cells from undergoing their natural death or self-destruction process, called apoptosis.


    Lead Product(s): Venetoclax,Azacitidine

    Therapeutic Area: Oncology Brand Name: Venclexta

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 12, 2022

    Abbvie Company Banner

    01

    AbbVie Inc

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    AbbVie to Showcase Oncology Portfolio and Pipeline During the 2022 ASCO and EHA Annual Congresses

    Details : VENCLEXTA®/VENCLYXTO® (venetoclax) is a first-in-class medicine that selectively binds and inhibits B-cell lymphoma-2 (BCL-2) protein. In some blood cancers, BCL-2 prevents cancer cells from undergoing their natural death or self-destruction process, c...

    Brand Name : Venclexta

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    May 12, 2022

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS)

    Details:

    VENCLEXTA®/VENCLYXTO® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein. In some blood cancers, BCL-2 prevents cancer cells from undergoing their natural death or self-destruction process, called apoptosis.


    Lead Product(s): Venetoclax,Azacitidine

    Therapeutic Area: Oncology Brand Name: Venclyxta

    Study Phase: Phase IIIProduct Type: Small molecule

    Sponsor: F. Hoffmann-La Roche

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 21, 2021

    Abbvie Company Banner

    02

    AbbVie Inc

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : F. Hoffmann-La Roche

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myel...

    Details : VENCLEXTA®/VENCLYXTO® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein. In some blood cancers, BCL-2 prevents cancer cells from undergoing their natural death or self-destruction proces...

    Brand Name : Venclyxta

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    July 21, 2021

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    AbbVie Gets +Ve CHMP Opinion for VENCLYXTO as a Combination Regimen for Adult Patients with Newly Diagnosed AML Ineligible for Chemotherapy

    Details:

    Positive opinion based on data from the VIALE-A and M14-358 trials, which evaluated the safety, efficacy and pharmacokinetics of VENCLYXTO in combination with hypomethylating agents in adult patients with AML.


    Lead Product(s): Venetoclax,Azacitidine

    Therapeutic Area: Oncology Brand Name: Venclyxto

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable April 23, 2021

    Abbvie Company Banner

    03

    AbbVie Inc

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    AbbVie Gets +Ve CHMP Opinion for VENCLYXTO as a Combination Regimen for Adult Patients with Newly ...

    Details : Positive opinion based on data from the VIALE-A and M14-358 trials, which evaluated the safety, efficacy and pharmacokinetics of VENCLYXTO in combination with hypomethylating agents in adult patients with AML.

    Brand Name : Venclyxto

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    April 23, 2021

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Health Canada Approves AbbVie's VENCLEXTA in Combination with Azacitidine Or Low Dose Cytarabine for Untreated Aml Français

    Details:

    In the VIALE-A trial, the median overall survival of patients who received VENCLEXTA plus azacitidine was 14.7 months (11.9, 18.7) vs 9.6 months (7.4, 12.7) in patients who received azacitidine in combination with placebo.


    Lead Product(s): Venetoclax,Azacitidine

    Therapeutic Area: Oncology Brand Name: Venclexta

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Genentech

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable December 15, 2020

    Abbvie Company Banner

    04

    AbbVie Inc

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Genentech

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Health Canada Approves AbbVie's VENCLEXTA in Combination with Azacitidine Or Low Dose Cytarabine f...

    Details : In the VIALE-A trial, the median overall survival of patients who received VENCLEXTA plus azacitidine was 14.7 months (11.9, 18.7) vs 9.6 months (7.4, 12.7) in patients who received azacitidine in combination with placebo.

    Brand Name : Venclexta

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    December 15, 2020

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    VENCLEXTA®/VENCLYXTO Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve ...

    Details:

    Phase 3 VIALE-A study showed a 34 percent reduction in the risk of death in AML patients who were ineligible for intensive chemotherapy treated with venetoclax plus azacitidine compared to azacitidine plus placebo.


    Lead Product(s): Venetoclax,Azacitidine

    Therapeutic Area: Oncology Brand Name: Venclexta

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Genentech

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 13, 2020

    Abbvie Company Banner

    05

    AbbVie Inc

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Genentech

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    VENCLEXTA®/VENCLYXTO Plus Azacitidine Demonstrates Statistically Significant Overall Survival Ben...

    Details : Phase 3 VIALE-A study showed a 34 percent reduction in the risk of death in AML patients who were ineligible for intensive chemotherapy treated with venetoclax plus azacitidine compared to azacitidine plus placebo.

    Brand Name : Venclexta

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    June 13, 2020

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ImmunoGen Presents Initial Findings From the Phase 1b/2 Study of IMGN632 in Combination With Vidaza® and Venclexta® in Relapsed/Refractory Acute Myelo...

    Details:

    The data reinforce the potential of IMGN632 as a new therapy for patients with relapsed/refractory AML and result showed that they manageable safety profile and 38% composite complete remission rate seen in the higher intensity cohorts.


    Lead Product(s): IMGN632,Azacitidine,Venetoclax

    Therapeutic Area: Oncology Brand Name: IMGN632

    Study Phase: Phase I/ Phase IIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable December 12, 2021

    Immunogen

    06

    Immunogen

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : IMGN632,Azacitidine,Venetoclax

    Therapeutic Area : Oncology

    Highest Development Status : Phase I/ Phase II

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    ImmunoGen Presents Initial Findings From the Phase 1b/2 Study of IMGN632 in Combination With Vidaz...

    Details : The data reinforce the potential of IMGN632 as a new therapy for patients with relapsed/refractory AML and result showed that they manageable safety profile and 38% composite complete remission rate seen in the higher intensity cohorts.

    Brand Name : IMGN632

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    December 12, 2021

    Immunogen

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ImmunoGen to Present Initial Data Combining IMGN632 with Vidaza® and Venclexta® in Relapsed/Refractory Acute Myeloid Leukemia at ASH

    Details:

    The data demonstrate the promising anti-leukemia activity and manageable safety profile of the IMGN632 triplet in AML, and we are encouraged by its potential in patients with relapsed/refractory AML, where well-tolerated, effective options remain quite limited.


    Lead Product(s): IMGN632,Azacitidine,Venetoclax

    Therapeutic Area: Oncology Brand Name: IMGN632

    Study Phase: Phase I/ Phase IIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable November 04, 2021

    Immunogen

    07

    Immunogen

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : IMGN632,Azacitidine,Venetoclax

    Therapeutic Area : Oncology

    Highest Development Status : Phase I/ Phase II

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    ImmunoGen to Present Initial Data Combining IMGN632 with Vidaza® and Venclexta® in Relapsed/Refr...

    Details : The data demonstrate the promising anti-leukemia activity and manageable safety profile of the IMGN632 triplet in AML, and we are encouraged by its potential in patients with relapsed/refractory AML, where well-tolerated, effective options remain quite l...

    Brand Name : IMGN632

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    November 04, 2021

    Immunogen

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEver Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances & suspensions.

    EVER Pharma receives EU marketing authorization for Azacitidine

    Details:

    Azacitidine EVER Pharma is a DNMT1/DNMT3A indicated for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.


    Lead Product(s): Azacitidine

    Therapeutic Area: Oncology Brand Name: Azacitidine EVER Pharma

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable March 12, 2021

    Ever Pharma CB

    08

    Ever Pharma

    Austria
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEver Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances & suspensions.

    Lead Product(s) : Azacitidine

    Therapeutic Area : Oncology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    EVER Pharma receives EU marketing authorization for Azacitidine

    Details : Azacitidine EVER Pharma is a DNMT1/DNMT3A indicated for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.

    Brand Name : Azacitidine EVER Pharma

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    March 12, 2021

    Ever Pharma CB

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Syros Announces Topline Data from Tamibarotene Phase 3 Trial

    Details:

    SY-1425 (tamibarotene) is a first-in-class selective RARα agonist, being evaluated in combination with azacitidine for higher-risk myelodysplastic syndrome with RARA gene overexpression.


    Lead Product(s): Tamibarotene,Azacitidine,Venetoclax

    Therapeutic Area: Oncology Brand Name: SY-1425

    Study Phase: Phase IIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable November 12, 2024

    blank

    09

    Syros Pharmaceuticals

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed

    Syros Pharmaceuticals

    U.S.A
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Tamibarotene,Azacitidine,Venetoclax

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Syros Announces Topline Data from Tamibarotene Phase 3 Trial

    Details : SY-1425 (tamibarotene) is a first-in-class selective RARα agonist, being evaluated in combination with azacitidine for higher-risk myelodysplastic syndrome with RARA gene overexpression.

    Brand Name : SY-1425

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    November 12, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Qurient Begins Adrixetinib Clinical Trial for Acute Myeloid Leukemia

    Details:

    Q702 (adrixetinib) is an orally administered, selective inhibitor of AXL/MER/CSF1R kinases, which is being evaluated for the treatment of acute myeloid leukemia.


    Lead Product(s): Adrixetinib,Azacitidine,Venetoclax

    Therapeutic Area: Oncology Brand Name: Q702

    Study Phase: Phase IProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 24, 2024

    blank

    10

    Qurient

    South Korea
    arrow
    American Pharma Summit
    Not Confirmed

    Qurient

    South Korea
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Adrixetinib,Azacitidine,Venetoclax

    Therapeutic Area : Oncology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Qurient Begins Adrixetinib Clinical Trial for Acute Myeloid Leukemia

    Details : Q702 (adrixetinib) is an orally administered, selective inhibitor of AXL/MER/CSF1R kinases, which is being evaluated for the treatment of acute myeloid leukemia.

    Brand Name : Q702

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    October 24, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    INTERMEDIATES SUPPLIERS

    read-more
    read-more

    01

    Louis Pharmaceuticals

    India
    BioFlorida Conference
    Not Confirmed
    arrow

    Louis Pharmaceuticals

    India
    BioFlorida Conference
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    1-O-acetyl-2,3,5-tri-O-benzoyl-beta D –Ribofuran...

    CAS Number : 6974-32-9

    End Use API : Azacitidine

    About The Company : Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is established in 2009 and has an integrated focus from vario...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Louis Pharmaceuticals

    India
    BioFlorida Conference
    Not Confirmed
    arrow

    Louis Pharmaceuticals

    India
    BioFlorida Conference
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    5-Aza Cytosine

    CAS Number : 931-86-2

    End Use API : Azacitidine

    About The Company : Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is established in 2009 and has an integrated focus from vario...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Tivan Sciences

    India
    BioFlorida Conference
    Not Confirmed
    arrow

    Tivan Sciences

    India
    BioFlorida Conference
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    5-Azacytosine

    CAS Number : 931-86-2

    End Use API : Azacitidine

    About The Company : Tivan Sciences is an API manufacturing company founded in January 2020 and located in Rajkot, Gujarat. The company is committed to developing high-quality produ...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    STOCK RECAP #PipelineProspector

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search